Market capitalization | €1.13b |
P/E (TTM) P/E ratio | 9.92 |
P/S ratio (TTM) P/S ratio | 0.33 |
P/B ratio (TTM) P/B ratio | 0.78 |
Dividend yield | 3.38% |
Last dividend (FY24) | €2.03 |
Revenue growth (TTM) Revenue growth | -0.08% |
Revenue (TTM) Revenue | €3.37b |
EBIT (operating result TTM) EBIT | €161.52m |
As a Free StocksGuide user, you can view scores for all 6,780 stocks worldwide.
7 Analysts have issued a Drägerwerk forecast:
7 Analysts have issued a Drägerwerk forecast:
Dec '24 |
+/-
%
|
||
Revenue | 3,371 3,371 |
0%
0%
|
|
Gross Profit | - - |
-
|
|
EBITDA | - - |
-
|
EBIT (Operating Income) EBIT | 162 162 |
10%
10%
|
Net Profit | 124 124 |
12%
12%
|
In millions EUR.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Drägerwerk AG & Co. KGaA engages in the provision of medical and safety technology products. It operates through the following geographical segments: Europe; Americas; and Africa, Asia, and Austria (AAA). The company was founded by Johann Heinrich Draeger in 1889 and is headquartered in Luebeck, Germany.
Head office | Germany |
CEO | Stefan Dräger |
Employees | 16,598 |
Founded | 1889 |
Website | www.draeger.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.